The Lucence liquid biopsy test costs more than US$1,000, which represents just 10 per cent to 20 per cent of the cost of a tissue biopsy, according to its founder. Photo: Shutterstock

Temasek unit-backed firm Lucence to tap Hong Kong cancer screening market

  • Expansion in Hong Kong will see Lucence compete with companies such as Sanomics and Prenetics
  • Singapore-based company has raised US$9.2 million in seed capital and is looking to raise another US$10 million or more
Topic |   Health & Fitness

TOP PICKS

The Lucence liquid biopsy test costs more than US$1,000, which represents just 10 per cent to 20 per cent of the cost of a tissue biopsy, according to its founder. Photo: Shutterstock
READ FULL ARTICLE
Eric Ng

Eric Ng

Eric joined the SCMP in 1998 after brief stints in a trading company and translation and editing roles at Dow Jones and Edinburgh Financial Publishing. He has close to 20 years of experience covering China's energy, mining and industrial materials sectors, and has recently added biotechnology to his coverage. Eric has a Masters of Business Administration degree.